CD14 and coronary artery disorder: By the application of antibodies against CD11b, HLA-DR, CD14 and CD16 followed by sequential gating steps, we were able to precisely identify classical, intermediate and non-classical monocytes in healthy persons and patients with CHD and STEMI.